scispace - formally typeset
A

A. K. Srivastava

Researcher at Central Drug Research Institute

Publications -  53
Citations -  1436

A. K. Srivastava is an academic researcher from Central Drug Research Institute. The author has contributed to research in topics: Glycosyl & Docking (molecular). The author has an hindex of 18, co-authored 49 publications receiving 1345 citations. Previous affiliations of A. K. Srivastava include Academy of Scientific and Innovative Research.

Papers
More filters
Journal ArticleDOI

Erratum to “Next Generation Sequencing: Potential and Application in Drug Discovery”.

TL;DR: Through this erratum the authors declare that two coauthors were missing in the article entitled “Next generation sequencing: potential and application in drug discovery”.
Journal ArticleDOI

Synthesis and antihyperglycemic activity of chalcone based aryloxypropanolamines.

TL;DR: Among them compounds 5a, g, m, o, p and r showed significant reduction in blood glucose levels in both SLM and STZ animal models.
Journal ArticleDOI

Antihyperglycemic and antidyslipidemic agent from Aegle marmelos

TL;DR: The reasonable mapping of compound 2 to validated pharmacophoric hypothesis and 3D QSAR model with an estimated activity suggest that the compound 2 might be a beta(3)-AR agonist.
Journal ArticleDOI

Synthesis of novel triterpenoid (lupeol) derivatives and their in vivo antihyperglycemic and antidyslipidemic activity.

TL;DR: The triterpenoid 4 lowered the blood glucose levels by 18.2% and 25.0% in sucrose challenged streptozotocin induced diabetic rats (STZ-S) model at the dose of 100mg/kg body weight.
Journal ArticleDOI

Application of click chemistry towards an efficient synthesis of 1,2,3-1H-triazolyl glycohybrids as enzyme inhibitors.

TL;DR: An efficient synthesis of novel 1,2,3-1H-triazolyl glycohybrids with two or more than two sugar units or a chromenone moiety via copper-catalysed azide-alkyne cycloaddition (CuAAC) with promising inhibitory activities against α-glucosidase, glycogen phosphorylase and glucose-6-phosphatase inhibitsory activities is described.